Creative Medical Technolo...

NASDAQ: CELZ · Real-Time Price · USD
3.05
-0.02 (-0.65%)
At close: Aug 15, 2025, 3:59 PM
3.12
2.30%
After-hours: Aug 15, 2025, 06:53 PM EDT

Creative Medical Technology Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a 3K 3K n/a 8K n/a 3K 6K n/a n/a 18.6K 55K 10K 15K 67.75K 10K 10K n/a
Cost of Revenue
30.74K 1.2K 1.2K -58.54K 32.47K 29.27K 26.72K 2.4K 23.02K 23.02K 5.7K 16K 4.5K 6.79K 39.45K 4K 4.5K 23.02K
Gross Profit
-30.74K 1.8K 1.8K 58.54K -24.47K -29.27K -23.72K 3.6K -23.02K -23.02K 12.9K 39K 5.5K 8.21K 28.3K 6K 5.5K -23.02K
Operating Income
-1.26M -1.66M -1.89M -1.11M -1.63M -1.12M -1.77M -1.54M -1.19M -1.11M -6.28M -1.02M -1.79M -1.15M -1.47M -833.44K -515.84K -303.94K
Interest Income
30.22K 22.38K 31.66K 69.54K 67.58K 81.6K 93.27K 89.23K 89.91K 61.2K 62.24K 38.08K n/a n/a n/a n/a n/a n/a
Pretax Income
-1.23M -1.64M -1.85M -1.04M -1.56M -1.04M -1.68M -1.45M -1.1M -1.05M -6.22M -982.34K -1.79M -1.15M -3.88M -1.84M -2.91M 27.84M
Net Income
-1.23M -1.64M -1.85M -1.04M -1.56M -1.04M -1.68M -1.45M -1.1M -990.78K -6.15M -982.34K -2.03M -1.15M -3.88M -1.84M -2.91M 27.84M
Selling & General & Admin
731.52K 888.4K 1.39M 498.61K 676.09K 671.48K 1.4M 531.04K 859.54K 771.02K 899.6K 805.46K 1.11M 1.13M 1.43M 757.24K 498.32K 280.92K
Research & Development
501.26K 743.3K 471.84K 581.8K 924.75K 422.39K 349.41K 992.72K 309.48K 319.03K 5.37M 230.94K 659.7K 10K 50K 59.18K n/a n/a
Other Expenses
n/a n/a 22.64K 29.27K n/a n/a n/a 23.02K n/a 23.02K 23.02K n/a 23.02K 23.02K -69.06K 23.02K 23.02K 23.02K
Operating Expenses
1.23M 1.63M 1.89M 1.11M 1.6M 1.09M 1.75M 1.55M 1.19M 1.11M 6.29M 1.06M 1.79M 1.16M 1.5M 839.44K 521.34K 303.94K
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a 50.00 n/a n/a n/a n/a 2.4M 1.31M 234.34K 336.08K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
1.26M 1.63M 1.89M 1.11M 1.63M 1.12M 1.77M 1.55M 1.19M 1.11M 6.3M 1.08M 1.79M 1.17M 1.54M 843.44K 525.84K 303.94K
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a -61.15K -62.24K n/a 234.34K n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
2.58M 1.98M 1.65M 1.39M 1.41M 1.42M 1.39M 1.43M 1.41M 1.41M 1.41M 1.41M 901.13K 645.4K 348.12K 245.21K 232.01K 227.71K
Shares Outstanding (Diluted)
2.58M 1.98M 1.65M 1.39M 1.41M 1.42M 1.39M 1.43M 1.41M 1.41M 1.41M 1.41M 901.13K 645.4K 633.89K 245.21K 232.01K 248.91K
EPS (Basic)
-0.48 -0.83 -1.12 -0.75 -1.11 -0.73 -1.21 -1.02 -0.78 -0.7 -4.37 -0.7 -2.25 -1.79 -11.13 -7.52 -12.52 122.20
EPS (Diluted)
-0.48 -0.83 -1.12 -0.75 -1.11 -0.73 -1.21 -1.02 -0.78 -0.7 -4.37 -0.7 -2.25 -1.79 -6.11 -7.52 -12.52 111.80
EBITDA
-1.2M -1.63M -1.83M -1.08M -1.6M -1.01M -1.75M -1.52M -1.17M -1.03M -6.19M -997.4K -1.77M -1.13M -1.45M -810.41K -492.82K -280.92K
EBIT
-1.23M -1.66M -1.97M -1.11M -1.63M -1.04M -1.77M -1.54M -1.19M -1.05M -6.22M -1.02M -1.79M -1.15M -1.47M -538.32K -2.67M 28.17M
Depreciation & Amortization
30.74K 30.58K 22.64K 29.27K 29.27K 29.27K 25.52K 23.02K 23.02K 23.02K 23.02K 23.02K 23.02K 23.02K 23.02K 23.02K 23.02K 23.02K